Volume 8, Issue 1, Pages (July 2014)

Slides:



Advertisements
Similar presentations
Volume 138, Issue 2, Pages (July 2009)
Advertisements

Volume 20, Issue 5, Pages (August 2017)
Volume 12, Issue 4, Pages (July 2015)
Jeroen Witteveldt, Alasdair Ivens, Sara Macias  Cell Reports 
Self-Excising Retroviral Vectors Encoding the Cre Recombinase Overcome Cre- Mediated Cellular Toxicity  Daniel P. Silver, David M. Livingston  Molecular.
Volume 14, Issue 4, Pages (October 2013)
Volume 46, Issue 6, Pages e5 (June 2017)
Volume 14, Issue 3, Pages (September 2013)
Volume 22, Issue 3, Pages (January 2018)
Volume 16, Issue 5, Pages (November 2014)
Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination  Konstantina Skourti-Stathaki, Nicholas J.
Volume 13, Issue 6, Pages (June 2013)
Volume 20, Issue 7, Pages (August 2017)
Volume 15, Issue 4, Pages (April 2014)
Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity  Tina.
Volume 22, Issue 3, Pages e5 (September 2017)
Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 
Volume 8, Issue 6, Pages (December 2010)
Wenqian Hu, Bingbing Yuan, Harvey F. Lodish  Developmental Cell 
Volume 4, Issue 3, Pages (September 2008)
Volume 5, Issue 6, Pages (December 2013)
Volume 20, Issue 5, Pages (August 2017)
Andrew J Henderson, Ruth I Connor, Kathryn L Calame  Immunity 
Slicing-Independent RISC Activation Requires the Argonaute PAZ Domain
Volume 24, Issue 11, Pages e3 (September 2018)
Volume 20, Issue 5, Pages (November 2016)
MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2  Ning Xu, Petter Brodin, Tianling Wei, Florian.
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Volume 37, Issue 1, Pages (January 2010)
Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling
Volume 6, Issue 6, Pages (March 2014)
Volume 15, Issue 9, Pages (May 2016)
Volume 9, Issue 5, Pages (November 2017)
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription  Chia-Hsin.
Volume 23, Issue 5, Pages (May 2018)
Volume 21, Issue 9, Pages (November 2017)
Volume 16, Issue 3, Pages (September 2014)
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Volume 18, Issue 6, Pages (December 2015)
Volume 12, Issue 2, Pages (August 2012)
Volume 5, Issue 2, Pages (February 2009)
Volume 10, Issue 3, Pages (March 2012)
Volume 5, Issue 3, Pages (November 2013)
Both Natural and Designed Micro RNAs Can Inhibit the Expression of Cognate mRNAs When Expressed in Human Cells  Yan Zeng, Eric J Wagner, Bryan R Cullen 
Volume 10, Issue 2, Pages (January 2015)
Melissa B. Uccellini, Adolfo García-Sastre  Cell Reports 
Volume 17, Issue 12, Pages (December 2010)
Jeroen Witteveldt, Alasdair Ivens, Sara Macias  Cell Reports 
Volume 138, Issue 2, Pages (July 2009)
Volume 27, Issue 1, Pages (July 2007)
Volume 5, Issue 6, Pages (December 2013)
Volume 13, Issue 7, Pages (November 2015)
Volume 5, Issue 6, Pages (December 2015)
Volume 18, Issue 5, Pages (May 2010)
Volume 44, Issue 5, Pages (May 2016)
Volume 4, Issue 1, Pages (July 2013)
Volume 3, Issue 1, Pages (January 2013)
Volume 20, Issue 10, Pages (September 2017)
Volume 9, Issue 2, Pages (February 2011)
Molecular Therapy - Nucleic Acids
Volume 5, Issue 4, Pages (November 2013)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Boyan Bonev, Peter Stanley, Nancy Papalopulu  Cell Reports 
Volume 15, Issue 4, Pages (April 2014)
Volume 21, Issue 3, Pages (March 2017)
Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation  Priya Bellare,
Volume 24, Issue 4, Pages (July 2018)
Volume 14, Issue 1, Pages (July 2013)
Volume 20, Issue 2, Pages (August 2016)
Volume 11, Issue 6, Pages (June 2012)
Presentation transcript:

Volume 8, Issue 1, Pages 114-125 (July 2014) The Mammalian Response to Virus Infection Is Independent of Small RNA Silencing  Simone Backes, Ryan A. Langlois, Sonja Schmid, Andrew Varble, Jaehee V. Shim, David Sachs, Benjamin R. tenOever  Cell Reports  Volume 8, Issue 1, Pages 114-125 (July 2014) DOI: 10.1016/j.celrep.2014.05.038 Copyright © 2014 The Authors Terms and Conditions

Cell Reports 2014 8, 114-125DOI: (10.1016/j.celrep.2014.05.038) Copyright © 2014 The Authors Terms and Conditions

Figure 1 Small RNA Profiling of Virus-Infected Cells (A) RNA-seq reads (18–25 nt) obtained from glial cells persistently infected with BDV or from fibroblasts infected with IAV, SV, and VSV (moi of 1 for 12 hr) were analyzed for size distribution. (B) VSV-derived reads from (A) were aligned for their distribution across the genome. (C) Northern blot analysis of wild-type (MEF) and dicer-deficient (Dcr−/−) cells infected with VSV (moi of 1 for 9 hr) for VSV-derived small RNA VSV318, miR-93, and U6. (D) Northern blot analysis of MEF and Dcr−/− cells infected with VSV (moi of 1 for 9 hr) for VSV-derived small RNA VSV11161, miR-93, and U6. See also Table S1. Cell Reports 2014 8, 114-125DOI: (10.1016/j.celrep.2014.05.038) Copyright © 2014 The Authors Terms and Conditions

Figure 2 VSV Does Not Encode an Inhibitor of RNAi (A) Schematic of the VSV genome engineered to encode four perfectly complementary miR-142 target (VSV142T) or four scrambled sites (VSVscbl) in the 3′ UTR of the mRNA encoding for the L protein. (B and C) Multicycle growth curve of VSVctrl, VSV142T, and VSVscbl on (B) RAW cells or (C) dicer-deficient cells (Dcr−/−). Supernatants were analyzed at the indicated time points by plaque assay. (D) Northern blot analysis of BHK transfected with miR-124 expressing plasmid (p124) or infected with VSV expressing miR-124 (VSV-124, moi of 1 for 16 hr) for miR-124 and U6. See also Figure S1. Cell Reports 2014 8, 114-125DOI: (10.1016/j.celrep.2014.05.038) Copyright © 2014 The Authors Terms and Conditions

Figure 3 Engineering VSV to Antagonize Small RNAs (A) Schematic of VACV VP55 insertion into the VSV genome. Each independent transcript is shown as it would be generated. An, polyadenylated tail. (B) Western blot analysis of VACV, VSVctrl, or VSV-VP55-infected BHK for VACV VP55, E3, and VSV G expression. (C) Northern blot analysis of BHK coinfected with VSV expressing miR-124 (VSV-124) and VACV, VSVctrl, or VSV-VP55 (moi of 1 for 12 hr) for miR-124, VSV-leader RNA, and U6. Relative density depicts mature miR-124/U6. (D) Analysis of murine fibroblasts transfected with control (scbl) or VSV-N-specific (VSV-N) siRNAs. At 6 hr posttransfection, cells were infected with VSVctrl or VSV-VP55 for 10 hr (moi of 1). Western blot was probed for VSV proteins and actin. (E) Schematic of pre-miR-146b-5p processing and the corresponding miRNA duplex (middle) and mature miRNAs (bottom). The mature miRNA sequence-specific reads were determined by sequencing of the 20–25 nt fraction of VSV-VP55-infected cells. Adenosines (A) in black depict nontemplated bases and the percent representation reflects the portion of the corresponding sequence in the total miRNA-specific tailed fraction. See also Figure S2. Cell Reports 2014 8, 114-125DOI: (10.1016/j.celrep.2014.05.038) Copyright © 2014 The Authors Terms and Conditions

Figure 4 Small RNAs Do Not Impact VSV Replication (A and B) Multicycle growth curve of VSVctrl and VSV-VP55 (moi of 0.01) on dicer-deficient cells (Dcr−/−). (A) Cells were analyzed at the indicated time points for expression of VSV proteins. (B) Supernatants were analyzed at the indicated time points by plaque assay. (C and D) Multicycle growth curve of VSVctrl and VSV-VP55 (moi of 0.01) on wild-type fibroblasts (MEFs). (C) Cells were analyzed at the indicated time points for expression of VSV proteins. (D) Supernatants were analyzed at the indicated time points by plaque assay. See also Figure S3. Cell Reports 2014 8, 114-125DOI: (10.1016/j.celrep.2014.05.038) Copyright © 2014 The Authors Terms and Conditions

Figure 5 Host miRNAs Target INF-Stimulated Genes during VSV Infection (A–D) BMMs were infected with VSVctrl or VSV-VP55 (moi of 5). (A) Viral replication was analyzed by plaque assay at the indicated time points. (B) At 24 hr postinfection, BMMs were analyzed by northern blot for the presence of cellular miRNAs (miR-93, miR-146, miR-155, and miR142) and U6. Relative density depicts miR-146/U6. (C) BMMs were analyzed at 10 hr postinfection by mRNA-seq. The top 40 protein-coding transcripts differentially regulated by VSV-VP55 infection are shown. (D) qRT-PCR depicting the levels of PTGS2, Ddx60, Rsad2, and Mx1 induction compared with endogenous tubulin levels in BMMs infected for 10 hr with VSVctrl or VSV-VP55. See also Table S2. Cell Reports 2014 8, 114-125DOI: (10.1016/j.celrep.2014.05.038) Copyright © 2014 The Authors Terms and Conditions

Figure 6 A Functional IFN Response Impacts VSV Replication (A) RNA-seq reads (18–25 nt) obtained from the lungs of mice infected intranasally with VSVctrl or VSV-VP55 (1 × 107 pfu for 24 hr) aligned for their distribution across the VSV-VP55 genome. GOI, gene of interest. (B) Wild-type mice were infected intranasally with VSVctrl or VSV-VP55 (1 × 107 pfu; three mice per virus). At 24 hr postinfection, lungs were analyzed for miR-146 and U6 expression by northern blot. M1, mouse 1; M2, mouse 2; M3, mouse 3. Relative density depicts mature miR-146/U6. (C) qRT-PCR depicting levels of IFN-β induction compared with endogenous tubulin levels in wild-type fibroblasts (MEFs) infected with VSVctrl, VSV-VP55, or VSV-NS1 (moi of 1 for 16 hr). (D) Wild-type mice were infected intranasally with VSVctrl, VSV-VP55, or VSV-NS1 (1 × 107 pfu). At 24 hr postinfection, the lungs and spleens were analyzed by plaque assay. Statistical analysis was performed on indicated samples using a two-tailed, unpaired Student’s t test. Data are considered significant if the p value is <0.05. (E) INF-I and INF-III receptor knockout mice (Ifnar1−/−/Il28r−/−) were infected intranasally with VSVctrl, VSV-VP55, or VSV-NS1 (1 × 104 pfu). At 48 hr postinfection, the lungs and spleens were analyzed by plaque assay. Statistical analysis was performed on indicated samples using a two-tailed, unpaired Student’s t test. Data are considered significant if the p value is <0.05. See also Figure S4 and Table S3. Cell Reports 2014 8, 114-125DOI: (10.1016/j.celrep.2014.05.038) Copyright © 2014 The Authors Terms and Conditions